Millennium Management’s Novavax NVAX Stock Holding History

Millennium Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-51,300	Closed	-$649K	–	6359
2024 Q2	$649K	Buy	+51,300	New	+$516K	﹤0.01%	4428
2023 Q4	–	Sell	-300,000	Closed	-$2.17M	–	6391
2023 Q3	$2.17M	Buy	+300,000	New	+$2.4M	﹤0.01%	3474
2022 Q3	–	Sell	-19,100	Closed	-$982K	–	7366
2022 Q2	$982K	Sell	19,100 -20,900	-52%	-$1.08M	﹤0.01%	4385
2022 Q1	$2.95M	Buy	+40,000	New	+$3.57M	﹤0.01%	3515
2021 Q4	–	Sell	-20,000	Closed	-$4.15M	–	7192
2021 Q3	$4.15M	Buy	20,000 +11,500	+135%	+$2.53M	﹤0.01%	3086
2021 Q2	$1.8M	Sell	8,500 -45,500	-84%	-$8.34M	﹤0.01%	4081
2021 Q1	$9.79M	Buy	54,000 +15,000	+38%	+$2.99M	0.01%	1796
2020 Q4	$4.35M	Buy	+39,000	New	+$4.15M	﹤0.01%	2577
2019 Q2	–	Sell	-195,000	Closed	-$2.15M	–	4345
2019 Q1	$2.15M	Buy	+195,000	New	+$6.16M	﹤0.01%	2360
2016 Q3	–	Sell	-10,000	Closed	-$1.45M	–	3504
2016 Q2	$1.45M	Buy	+10,000	New	+$1.15M	﹤0.01%	1960

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's NVAX Position: Q1 2026 in Review

Millennium Management reduced its Novavax (NVAX) stake by 14% in Q1 2026, selling an estimated $5.6M and leaving 3,852,545 shares worth $31.4M. The position accounts for 0.01% of the portfolio, ranked #1194.

Millennium Management first reported a position in NVAX in Q3 2013 and has held it in 49 quarters since. The position peaked at $68.9M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Millennium Management held 3,852,545 shares of Novavax worth $31.4M as of Q1 2026.
Millennium Management sold 617,538 Novavax shares in Q1 2026, an estimated $5.6M.
Novavax made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1194 holding.
Millennium Management first reported a position in Novavax in Q3 2013 and has held it in 49 quarters since.
Millennium Management's Novavax position peaked at $68.9M in Q2 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.